New glucose meter put to the test in 219 patients
NCT ID NCT07353125
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested how accurately the LS-9 blood glucose monitor measures blood sugar in 219 people with diabetes. Participants had their blood sugar measured using the device and a standard lab method. The goal was to see if the LS-9 meets international accuracy standards for home glucose monitoring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If the LS-9 monitor proves accurate, it could offer a reliable new option for people with diabetes to check their blood sugar at home.
- What could go wrong
- This is a device accuracy study, not a treatment trial. Even if accurate, it does not improve diabetes outcomes directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut für Diabetes Karlsburg GmbH
Karlsburg, Mecklenburg-Vorpommern, 17495, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could diabetes be silently damaging your hearing?
- Press play on better health: could recording doctor visits boost Self-Care in seniors?
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- A simple card game could transform diabetes care
- Can a new injection help tackle obesity and diabetes? a safety trial begins